Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
J Infect Dis. Author manuscript; available in PMC 2009 Nov 12.
Published in final edited form as:
PMCID: PMC2776734

Borrelia burgdorferi Genotype Predicts the Capacity for Hematogenous Dissemination during Early Lyme Disease



Lyme disease, the most common tickborne disease in the United States, is caused exclusively by Borrelia burgdorferi sensu stricto in North America. The present study evaluated the genotypes of >400 clinical isolates of B. burgdorferi recovered from patients from suburban New York City with early Lyme disease associated with erythema migrans; it is the largest number of borrelial strains from North America ever to be investigated.


Genotyping was performed by restriction fragment–length polymorphism polymerase chain reaction analysis of the 16S–23S ribosomal RNA spacer and reverse line blot analysis of the outer surface protein C gene (ospC). For some isolates, DNA sequence analysis was also performed.


The findings showed that the 16S–23S ribosomal spacer and ospC are in strong linkage disequilibrium. Most B. burgdorferi genotypes characterized by either typing method were capable of infecting and disseminating in patients. However, a distinct subset of just 4 of the 16 ospC genotypes identified were responsible for >80% of cases of early disseminated Lyme disease.


This study identified the B. burgdorferi genotypes that pose the greatest risk of causing hematogenous dissemination in humans. This information should be considered in the future development of diagnostic assays and vaccine preparations.

Lyme disease is a tickborne zoonosis that occurs globally in the Northern Hemisphere [1, 2]. In North America, Lyme disease appears to be caused exclusively by Borrelia burgdorferi sensu stricto, whereas in Europe other species of Borrelia predominate [36]. A variety of typing systems exist to distinguish genetically distinct strains of B. burgdorferi [3]. On the basis of restriction fragment–length polymorphism (RFLP) of the 16S–23S rRNA intergenic spacer, B. burgdorferi has been classified into 3 distinct genetic subgroups (herein called genotypes), arbitrarily called ribosomal spacer type (RST) 1, RST2, and RST3 [7, 8]. Greater separation into distinct genotypes is achievable on the basis of the sequence heterogeneity of the outer surface protein C gene (ospC) [9, 10]. Genetically distinct genotypes of B. burgdorferi appear to differ ecologically and epidemiologically [1114], suggesting that genotype classification is relevant to understanding the basic biology of the spirochete.

Differential pathogenicity of B. burgdorferi on the basis of genotype has been reported in several studies. For example, in an analysis of 104 borrelial strains recovered from the skin of patients with a diagnosis of erythema migrans in Westchester County, New York, it was found that patients with disseminated infection (i.e., positive blood culture and/or multiple erythema migrans skin lesions) were at least 5 times more likely to have been infected with RST1 strains of B. burgdorferi than with RST3 strains [15]. A subsequent study of patients from Connecticut and Rhode Island with erythema migrans similarly found that infections believed to have disseminated were 5 times more common among RST1-infected patients compared with those infected with RST3 strains of B. burgdorferi [16]. In a study from New York State, dissemination of B. burgdorferi to blood or cerebrospinal fluid (CSF) was exclusively associated with ospC genotypes A, B, I, or K [9]. Subsequent studies from other geographic areas, however, have suggested that hematogenous dissemination is not restricted to just these 4 ospC genotypes [1618].

The present study was undertaken to evaluate the relationship between RST and ospC genotypes and to examine the association between specific genotypes and objective evidence of dissemination of the spirochete in patients, using the largest sample of clinical isolates of B. burgdorferi studied to date. In addition, the frequency distribution of RST and ospC genotypes in the skin or blood of patients with culture-confirmed erythema migrans was compared with that present in local tick populations.


Subjects, clinical specimens, and cultures

All human subjects were adults with erythema migrans enrolled in prospective studies at the Lyme Disease Practice of the Westchester Medical Center between 1991 and 2005. This practice serves patients in suburban New York City who live or work in the lower Hudson Valley of New York State. Specimens from skin, whole blood, serum, or plasma were collected and cultured as described elsewhere [15, 19].

Typing of B. burgdorferi strains

B. burgdorferi DNA was isolated from low-passage (1–5) cultures using a nucleic acid extraction kit (IsoQuick; Orca Research). A 941-bp fragment of the 16S–23S intergenic spacer was amplified by polymerase chain reaction (PCR) using primers PA and P95, as described elsewhere [7]. PCR-based RFLP analyses of the 16S–23S intergenic spacer were performed using the restriction enzyme Tru1I (Fermentas) [8, 20]. A 522-bp region of ospC was amplified by PCR using external primers OC6(+) and OC623(−) and internal primers OC6(+Fluo) and OC602(−) [11, 21]. Amplicons were then probed with ospC type–specific probes by reverse line blot [11, 21]. The ospC amplicons that did not hybridize with any ospC type–specific probes were reamplified and sequenced in both directions (Genewiz) using either primer set ospC-N/ospC-C [5] or OC6(+)/OC623(−). Isolates that produced ambiguous sequence results were cloned by limiting dilution, and sequence analyses were performed on 2 clones from each isolate. Some of the isolates in the present study have been reported in the context of other investigations of the pathogenicity of particular genotypes of B. burgdorferi [9, 15, 2224]. The ospC typing of B. burgdorferi in extracts from infected ticks was done by reverse line blotting, essentially as described above and elsewhere [11, 21].

Statistical analyses

Differences in the frequency distributions of genotypes were assessed using a χ2 analysis [25]. P values were estimated using a Monte Carlo simulation with 100,000 replicates when the marginal values summed to <5, making the χ2 distribution inappropriate [26]. The Bonferroni correction for multiple tests (P = .05/number of tests) was applied where appropriate in determining statistical significance [25]. Analyses were performed in R [27].


Genotyping of B. burgdorferi isolates from patients with early Lyme disease

B. burgdorferi isolates were obtained from either the skin or blood of 374 adult patients with erythema migrans evaluated at the Lyme Disease Practice of the Westchester Medical Center. RST genotyping was performed on 462 isolates (319 from skin and 143 from blood), and ospC genotyping was performed on 432 isolates (298 from skin and 134 from blood). At least 16 skin cultures and at least 5 blood cultures grew more than a single genotype of B. burgdorferi, on the basis of RST and/or ospC genotyping. Among the 94 patients infected with only a single genotype in skin and for whom a blood culture was positive and the isolates typed, the same genotype of B. burgdorferi grew from blood in 82 (87.2%). The blood culture yielded a different genotype for the other 12 patients; for 9 patients a single genotype was obtained from blood and for 3 patients 2 genotypes were obtained, only 1 of which was the same genotype as that recovered from skin. Patients for whom >1 genotype of B. burgdorferi was cultured on the basis of a particular genotyping method were excluded from the analyses described below.

Association between specific B. burgdorferi genotypes and dissemination

In this article the terms “invasive infection” and “disseminated infection” are used interchangeably. The frequency distribution of RST genotypes of B. burgdorferi strains recovered from either blood or skin during 1991–1996 did not significantly differ from those recovered during 1997–2005, when the high-volume plasma culture method [15] was performed routinely (data not shown). Therefore, all analyses reported here are for the entire 15-year time interval.

All 3 RST genotypes and at least 12 ospC genotypes were capable of hematogenous dissemination. However, the frequency distribution of RST genotypes among strains of B. burgdorferi recovered from skin differed from that among strains recovered from blood (Pearson’s χ2 test, χ2 = 8.8 and P = .01) (table 1). Table 2 shows a similar result based on ospC typing (Pearson’s χ2 test, χ2 = 27.4 and P = .017).

Table 1
Frequency distribution of ribosomal spacer type (RST) genotypes of Borrelia burgdorferi in skin and blood cultures from patients from suburban New York City with erythema migrans evaluated between 1991 and 2005.
Table 2
Frequency distribution of ospC genotypes of Borrelia burgdorferi in skin and blood cultures from patients from suburban New York City with erythema migrans evaluated between 1991 and 2005.

The relationship between RST and ospC genotypes among 422 isolates of B. burgdorferi obtained from clinical specimens of skin or blood was analyzed (table 2). The results indicate that the 16S–23S intergenic spacer region is in strong linkage disequilibrium with the gene encoding OspC. Each RST genotype was associated with 2 or more ospC genotypes. RST1 corresponded uniquely to ospC genotypes A and B; RST2 only to ospC genotypes F, H, K, and N; and RST3 to the remaining 10 ospC genotypes found among the strains that were evaluated (C, D, E, G, I, J, M, O, T, and U).

The prevalence among patients with a positive blood culture or multiple erythema migrans skin lesions was evaluated specifically for 249 patients with a positive skin culture in whom both blood and skin cultures were performed at the time of presentation. More than half of these patients (51.4%) had evidence of disseminated infection (either a positive blood culture or multiple erythema migrans skin lesions). An association was seen between RST genotype and the presence of disseminated infection (Pearson’s χ2 test, χ2 = 10.6 and P = .005) (table 3). The presence of spirochetemia (a positive blood culture) was also contingent on RST genotype (Pearson’s χ2 test, χ2 = 7.9 and P = .02). In both circumstances, RST1 was overrepresented in blood, and RST3 was underrepresented. Although the frequency of having multiple erythema migrans skin lesions varied across RST genotypes, there was no association between the presence of multiple erythema migrans skin lesions and RST type (Pearson’s χ2 test, χ2 = 0.9 and P = .69). The frequency distribution of ospC genotypes among total infections differed from the distribution among disseminated infections (Pearson’s χ2 test, χ2 = 43.7435 and P < .001) and from the distribution among either patients with spirochetemia (Pearson’s χ2 test, χ2 = 37.8098 and P < .001) or patients with multiple erythema migrans skin lesions (Pearson’s χ2 test, χ2 = 28.7819 and P = .02). All differences were statistically significant after correction for 2 posthoc tests (α = .025).

Table 3
Frequency of disseminated infection (positive blood culture and/or multiple erythema migrans [EM] skin lesions) by ribosomal spacer type (RST) genotype among patients from suburban New York City with EM whose skin culture was positive for Borrelia burgdorferi ...

Several ospC genotypes represented within the RST3 genotype (ospC genotypes C, D, J, O, and T) were infrequently recovered from either skin or blood specimens (table 2). When the analysis was restricted to those ospC genotypes represented by at least 5 skin isolates of B. burgdorferi, it was clear that the most invasive ospC genotypes were I, A, H, and B, each of which was associated with disseminated infection in >50% of patients infected in the skin with the same genotype (table 4). Both of the ospC genotypes within the RST1 genotype were highly invasive, whereas only genotype H within RST2 was comparably invasive. Among the ospC genotypes within the RST3 genotype, only ospC genotype I was frequently associated with dissemination, and no RST3-associated ospC genotypes were cultivated from blood more than once, except for genotypes I and C. Indeed, cutaneous infection due to ospC genotypes D, O, T, and U was never associated with either spirochetemia or the presence of multiple erythema migrans skin lesions. Although ospC genotype I was the single most commonly isolated genotype in the RST3 genotype, it comprised only 24.4% of the 82 RST3 strains recovered from skin.

Table 4
Frequency of disseminated infection (positive blood culture and/or multiple erythema migrans [EM] skin lesions) by ospC genotype among patients from suburban New York City whose skin culture was positive for Borrelia burgdorferi.

B. burgdorferi genotype frequency in ticks versus patients with early Lyme disease

Ixodes scapularis nymphs transmit B. burgdorferi to the majority of patients with Lyme disease in the northeastern United States. Therefore, we attempted to compare the frequency distribution of RST and ospC genotypes of B. burgdorferi among patients with that found among questing I. scapularis nymphs collected from the same region (lower Hudson Valley, New York) during an overlapping time period (2002–2004) [11, 28]. Because the frequency distribution of RST and ospC genotypes did not differ significantly among nymphs between years (Pearson’s χ2 test, χ2 = 30.1 and P = .45), tick data from 2002–2004 were pooled. The ospC genotype in these ticks was determined on the basis of direct PCR testing of the ticks; the RST genotype was not determined directly, but, given the strong association between the RST locus and ospC alleles demonstrated above and in other publications [2931], the RST genotype was inferred from the ospC genotype. Overall, the frequency distribution observed among ticks differed significantly from that found in either skin or blood for both RST (Pearson’s χ2 test for ticks vs. blood, χ2 = 32.3 and P < .001; Pearson’s χ2 test for ticks vs. skin, χ2 = 17.4 and P < .001) and ospC genotype (Pearson’s χ2 test for ticks vs. blood, χ2 = 93.7 and P < .001; Pearson’s χ2 test for ticks vs. skin, χ2 = 66.0 and P < .001) (table 5). RST1 strains increased in frequency from 22.8% among infected ticks to 28.6% of skin isolates and 37.9% of blood isolates. RST2 strains were found in 33.7% of infected ticks, compared with 43.1% of skin isolates and 45.5% of blood isolates. The frequency of RST3 strains decreased steadily from 43.5% among infected ticks to 28.3% of skin isolates and 16.7% of blood isolates. Five ospC genotypes (A, B, C, I, and K) showed a progressive increase in frequency from ticks to skin to blood, whereas 7 ospC genotypes (D, E, F, G, J, M, and T) showed a progressive decrease; 4 showed no consistent pattern (table 5).

Table 5
Comparison of the frequency distribution of different genotypes of Borrelia burgdorferi among infected nymphal stage Ixodes scapularis ticks with that found in the skin or blood of infected patients.


This investigation involved an analysis of the largest collection of clinical isolates of B. burgdorferi from the United States ever studied. B. burgdorferi can be subdivided into 3 distinct genotypes on the basis of an RFLP typing system of the 16S–23S rRNA intergenic spacer region and into at least 16 different ospC genotypes. Each of the ospC genotypes is in strong linkage disequilibrium with a specific RST genotype. For example, all of the 130 strains of ospC genotype K that were analyzed fell into the RST2 genotype, and all of the 77 strains of ospC genotype A were typed as RST1. These findings confirm and extend the findings of another study with fewer specimens [16] and support those of other investigators who demonstrated that isolates of B. burgdorferi are mostly clonal [32, 33].

The findings of the present study demonstrate that certain genotypes of B. burgdorferi are more invasive than others and clarify the role of each of the typing systems evaluated in identifying highly invasive strains. A significant association was observed between RST genotype and disseminated infection, with RST3 infections being the least invasive and RST1 infections the most (table 3). However, one of the ospC genotypes comprising the RST3 genotype, genotype I, was highly invasive. This ospC genotype was associated with the highest prevalence of both spirochetemia (76.9%) and multiple erythema migrans skin lesions (61.5%) compared with any of the other relatively common ospC genotypes, irrespective of RST genotype (table 4). Thus, of the 2 typing systems evaluated here, the ospC genotyping system was the more informative for defining the risk of disseminated B. burgdorferi infection in humans.

Note that the 16S–23S rRNA intergenic spacer is a noncoding sequence that should not contribute to pathogenicity but rather must be linked to pathogenicity-determining loci. In contrast, OspC is required for migration of spirochetes from the tick mid-gut to the salivary glands and/or for establishing initial infection in a mammal [34, 35]. However, given the observed linkage disequilibrium between the 16S–23S rRNA intergenic spacer and ospC (the former located on the chromosome and the latter on a circular plasmid), it is possible that ospC is also in linkage with other loci that are required for dissemination.

An earlier study that included fewer clinical isolates concluded that only ospC genotypes A, B, I, and K are invasive [9]. The present study demonstrates that, in fact, most ospC genotypes can cause spirochetemia on occasion, but the most invasive ospC genotypes in humans, in descending order, were I, A, H, and B. However, because genotype K infections were more common than infections due to other genotypes, this genotype was the one most frequently associated with disseminated infection in patients (tables 4 and and6);6); conversely, genotype H infections were generally infrequent and therefore were responsible for dissemination in a much smaller number of cases (6 cases of disseminated infection for genotype H vs. 32 for genotype K). Genotype H is comparatively rare among both ticks and primary skin infections (table 5). Therefore, in our geographic area, the 4 ospC genotypes A, B, I, and K comprise >80% of the cases of culture-confirmed early Lyme disease associated with spirochetal dissemination, although they comprise only 45.7% of the borrelial strains found in representative nymphal tick populations from the lower Hudson Valley. A limitation of our study is that, for several ospC genotypes, the number of infected patients was too small for us to evaluate invasive capability confidently. Nevertheless, our findings have potential implications for inclusion of particular ospC antigen(s) in diagnostic assays that incorporate this antigen [36] and for identifying highly clinically relevant Borrelia strains to evaluate the efficacy of experimental Lyme disease vaccines.

Table 6
Hierarchical analysis of invasive Borrelia burgdorferi infection among patients from suburban New York City with erythema migrans.

In agreement with other studies [9, 24], our data also suggest that there is differential pathogenicity for most strains of B. burgdorferi, not only between skin and blood but also between I. scapularis nymphs and skin. Of the common ospC genotypes, most within the RST3 genotype (except for I and U) and 2 of the 4 ospC genotypes within RST2 (F and H) were underrepresented in skin compared with their frequency in regional ticks, suggesting that these are the least pathogenic strains of B. burgdorferi for humans. These results should be viewed cautiously, however, because the data on the frequency of B. burgdorferi genotypes among the field-collected ticks considered in our analysis may not be representative of the actual ticks parasitizing humans in our region during the entire duration of this study. In addition, identification of infections in ticks was based on PCR of tick material, whereas identification of infections in patients was based on PCR of cultured isolates of B. burgdorferi. In our experience, cultures of skin biopsy specimens are negative in ~45% of patients with a clinical diagnosis of erythema migrans who can be shown to have B. burgdorferi infection on the basis of PCR and/or serologic evidence [37]. The strains of B. burgdorferi that appear to be underrepresented in skin relative to ticks may have been responsible for infection in such culture-negative cases. In addition, patients with coinfection in skin were excluded from this study and in general may be underappreciated by culture; therefore, failure to recognize or consider coinfection could be another factor contributing to the apparent underrepresentation of certain strains of B. burgdorferi in skin relative to ticks. Strains of B. burgdorferi that grow least well in culture would be systematically underrepresented in studies based on culture [8]. Alternatively, it is theoretically possible that B. burgdorferi strains that appear to be underrepresented in skin may have disseminated without causing erythema migrans. In certain European studies, it has been observed that strains of Borrelia garinii are underrepresented in cultures of erythema migrans relative to the frequency with which this species can be demonstrated in regional ticks but overrepresented in cases of neuroborreliosis associated with a positive CSF culture [38].

In summary, our findings establish that the 16S–23S rRNA intergenic spacer region and ospC are in strong linkage disequilibrium owing to the clonal nature of B. burgdorferi clinical isolates. Additionally, the study further strengthens the concept that a distinct subset of B. burgdorferi genotypes is responsible for the vast majority of cases of early disseminated Lyme disease in suburban New York City. Thus, although most B. burgdorferi genotypes are capable of producing human infection, several factors appear to contribute to the ability of specific B. burgdorferi genotypes to cause disseminated infection. These include the prevalence of the specific genotype among the local nymphal tick population, the transmissibility of a particular genotype from tick to human skin, and the ability of that genotype to disseminate from the initial site of skin infection to blood. It should be noted that the present study focused on hematogenous dissemination. Little is currently known regarding the relationship between B. burgdorferi genotype and invasion of sites such as CSF or joints. Classifying strains of B. burgdorferi into 1 of 3 RST genotypes or 1 of 16 ospC genotypes is useful for identifying those strains that pose the greatest risk of hematogenous dissemination. Furthermore, these findings should be considered in the future development of diagnostic assays and vaccine preparations.


National Institutes of Health (grant AR41511 to I.S.).

We thank Susan Bittker, Denise Cooper, and Donna McKenna for their contributions to this work.


Potential conflicts of interest: none reported.


1. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet. 1998;352:557–65. [PubMed]
2. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362:1639–47. [PubMed]
3. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev. 1999;12:633–53. [PMC free article] [PubMed]
4. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology. 2004;129(Suppl 1):S191–220. [PubMed]
5. Wang G, van Dam AP, Dankert J. Phenotypic and genetic characterization of a novel Borrelia burgdorferi sensu lato isolate from a patient with Lyme borreliosis. J Clin Microbiol. 1999;37:3025–8. [PMC free article] [PubMed]
6. Richter D, Schlee DB, Allgower R, Matuschka FR. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov. with its hosts in Central Europe. Appl Environ Microbiol. 2004;70:6414–9. [PMC free article] [PubMed]
7. Liveris D, Gazumyan A, Schwartz I. Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol. 1995;33:589–95. [PMC free article] [PubMed]
8. Liveris D, Varde S, Iyer R, et al. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol. 1999;37:565–9. [PMC free article] [PubMed]
9. Seinost G, Dykhuizen DE, Dattwyler RJ, et al. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun. 1999;67:3518–24. [PMC free article] [PubMed]
10. Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics. 1999;151:15–30. [PMC free article] [PubMed]
11. Brisson D, Dykhuizen DE. ospC diversity in Borrelia burgdorferi: different hosts are different niches. Genetics. 2004;168:713–22. [PMC free article] [PubMed]
12. Brisson D, Dykhuizen DE, Ostfeld RS. Conspicuous impacts of inconspicuous hosts on the Lyme disease epidemic. Proc Biol Sci. 2008;275:227–35. [PMC free article] [PubMed]
13. Hanincová K, Ogden NH, Diuk-Wasser M, et al. Fitness variation of Borrelia burgdorferi sensu stricto strains in mice. Appl Environ Microbiol. 2007;74:153–7. [PMC free article] [PubMed]
14. Hanincová K, Kurtenbach K, Diuk-Wasser M, Brei B, Fish D. Epidemic spread of Lyme borreliosis, northeastern United States. Emerg Infect Dis. 2006;12:604–11. [PMC free article] [PubMed]
15. Wormser GP, Liveris D, Nowakowski J, et al. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis. 1999;180:720–5. [PubMed]
16. Jones KL, Glickstein LJ, Damle N, Sikand VK, McHugh G, Steere AC. Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease. J Clin Microbiol. 2006;44:4407–13. [PMC free article] [PubMed]
17. Earnhart CG, Buckles EL, Dumler JS, Marconi RT. Demonstration of OspC type diversity in invasive human Lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect Immun. 2005;73:7869–77. [PMC free article] [PubMed]
18. Alghaferi MY, Anderson JM, Park J, et al. Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes. J Clin Microbiol. 2005;43:1879–84. [PMC free article] [PubMed]
19. Schwartz I, Wormser GP, Schwartz JJ, et al. Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol. 1992;30:3082–8. [PMC free article] [PubMed]
20. Liveris D, Wang G, Girao G, et al. Quantity of Borrelia burgdorferi detected in 2 mm skin samples of erythema migrans lesions: correlation with clinical and laboratory findings. J Clin Microbiol. 2002;40:1249–53. [PMC free article] [PubMed]
21. Qiu WG, Dykhuizen DE, Acosta MS, Luft BJ. Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the northeastern United States. Genetics. 2002;160:833–49. [PMC free article] [PubMed]
22. Wang G, Ojaimi C, Iyer R, et al. Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun. 2001;69:4303–12. [PMC free article] [PubMed]
23. Wang G, Ojaimi C, Wu H, et al. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis. 2002;186:782–91. [PMC free article] [PubMed]
24. Dykhuizen DE, Brisson D, Sandigursky S, et al. The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg. 2008;78:806–10. [PMC free article] [PubMed]
25. Sokal RR, Rohlf FJ. Biometry. New York: WH Freeman; 1995.
26. Hope ACA. A simplified Monte Carlo significance test procedure. J Royal Stat Soc B. 1968;30:582–98.
27. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2005.
28. Brisson D. PhD thesis. Stony Brook, NY: Stony Brook University; 2006. Effect of host community composition on the diversity and abundance of Lyme disease.
29. Attie O, Bruno JF, Xu Y, Qiu D, Luft BJ, Qiu WG. Co-evolution of the outer surface protein C gene (ospC) and intraspecific lineages of Borrelia burgdorferi sensu stricto in the northeastern United States. Infect Genet Evol. 2007;7:1–12. [PubMed]
30. Bunikis J, Garpmo U, Tsao J, Berglund J, Fish D, Barbour AG. Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology. 2004;150:1741–55. [PubMed]
31. Qiu WG, Schutzer SE, Bruno JF, et al. Genetic exchange and plasmid transfers in Borrelia burgdorferi sensu stricto revealed by three-way genome comparisons and multilocus sequence typing. Proc Natl Acad Sci USA. 2004;101:14150–5. [PMC free article] [PubMed]
32. Dykhuizen DE, Baranton G. The implications of a low rate of horizontal transfer in Borrelia. Trends Microbiol. 2001;9:344–50. [PubMed]
33. Dykhuizen DE, Polin DS, Dunn JJ, et al. Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development. Proc Natl Acad Sci USA. 1993;90:10163–7. [PMC free article] [PubMed]
34. Grimm D, Tilly K, Byram R, et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci USA. 2004;101:3142–7. [PMC free article] [PubMed]
35. Pal U, Yang X, Chen M, et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest. 2004;113:220–30. [PMC free article] [PubMed]
36. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis. 2003;187:1187–99. [PubMed]
37. Nowakowski J, Schwartz I, Liveris D, et al. Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis. 2001;33:2023–7. [PubMed]
38. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49:13–21. [PubMed]
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    NCBI Bookshelf books that cite the current articles.
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...